Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pet-ct”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03474341
What this trial is testing

Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Esophageal CancerEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+1 more
UMC Utrecht 200
Not applicableStudy completedNCT00388024
What this trial is testing

PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Carcinoma of Unknown PrimaryHead and Neck Cancer
Wake Forest University Health Sciences 19
Not applicableStudy completedNCT00004891
What this trial is testing

PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center 149
Not applicableLooking for participantsNCT05855941
What this trial is testing

Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)

Who this might be right for
Cervix CancerEndometrial CancerEpithelial Ovarian Cancer
Region Västerbotten 120
Not applicableStudy completedNCT01276483
What this trial is testing

Treatment Response Evaluation in Gastrointestinal Stromal Tumor (GIST) Patients

Who this might be right for
Soft Tissue NeoplasmsGastrointestinal Tract
Oslo University Hospital 40
Not applicableStudy completedNCT06190574
What this trial is testing

Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid Blastoma

Who this might be right for
18F-FDGNeuroblastomaHepatoblastoma+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Not applicableLooking for participantsNCT06690983
What this trial is testing

Tau PET/CT in Various Tau-Related Disease Patients

Who this might be right for
TauopathiesNeurodegenerative DiseasesNeurodegeneration
Tianjin Medical University 500
Testing effectiveness (Phase 2)Looking for participantsNCT07175480
What this trial is testing

PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Renal Cell Carcinoma (mRCC)
Jinling Hospital, China 30
Large-scale testing (Phase 3)WithdrawnNCT01652261
What this trial is testing

Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)

Who this might be right for
Hodgkin Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC
Early research (Phase 1)Looking for participantsNCT07144085
What this trial is testing

Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.

Who this might be right for
TumorMetastatic Cancer
Yi Tian 30
Testing effectiveness (Phase 2)Ended earlyNCT04365660
What this trial is testing

18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma

Who this might be right for
Osteosarcoma
Davidzon, Guido, M.D. 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07705074
What this trial is testing

FAPI PET Imaging - An Exploratory Study

Who this might be right for
Thyroid PathologyHead and Neck Cancer (H&N)Sinonasal Tract Tumor+14 more
Martin Huellner 770
Testing effectiveness (Phase 2)WithdrawnNCT04757090
What this trial is testing

89Zr-Trastuzumab PET/CT in Subjects With Previously Treated HER2-Positive Solid Tumors Scheduled to Receive Treatment With MT-5111

Who this might be right for
HER2-positive Solid TumorHER-2 Positive Cancer
Washington University School of Medicine
Not applicableStudy completedNCT03765424
What this trial is testing

Evaluation of Ultrasound and PET/CT in the Diagnosis and Monitoring of Giant Cell Arteritis

Who this might be right for
Giant Cell ArteritisVasculitis
University of Aarhus 101
Not applicableStudy completedNCT00963755
What this trial is testing

F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
University of Lausanne Hospitals 60
Not applicableStudy completedNCT07827482
What this trial is testing

Pretreatment 18F-FDG PET/CT Radiomics for Predicting Response to First-Line Targeted Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
First Affiliated Hospital of Fujian Medical University 228
Not applicableUnknownNCT05361135
What this trial is testing

18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia

Who this might be right for
Staphylococcus Aureus BacteremiaStaphylococcus Aureus SepticemiaSepsis Bacterial+4 more
University College, London 820
Not applicableStudy completedNCT00382252
What this trial is testing

PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung Metastases

Who this might be right for
Metastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Institut Bergonié 89
Not applicableStudy completedNCT03065725
What this trial is testing

Early Versus Late FDG-PET/CT in Bladder Cancer

Who this might be right for
Bladder Cancer
Jørgen Bjerggaard Jensen 179
Testing effectiveness (Phase 2)Looking for participantsNCT06103838
What this trial is testing

18F-Fluciclovine PET/CT in Multiple Myeloma

Who this might be right for
Multiple MyelomaNewly Diagnosed Multiple Myeloma (NDMM)Relapsed and/or Refractory Multiple Myeloma (RRMM)
National Cancer Institute (NCI) 60
Next Page